ALLISON PAGAN: Open Payments
NPI 1295230068 · MISSOURI VALLEY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 35 payments from 13 companies in 2025. Trend: 2023 $426 · 2024 $302 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $142 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $80 |
| Novo Nordisk Inc | 4 | $70 |
| ABBVIE INC. | 2 | $45 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Viatris Specialty LLC | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
Products named: MOUNJARO, JOURNAVX, Ozempic, JARDIANCE, INSPIRE, CAPLYTA, YUPELRI, Qelbree.
Industry payments across IA — which companies pay providers there.
